StockVS

NASDAQ · Pharmaceutical Retailers · USD

High Tide Inc. (HITI) Stock Analysis

High Tide Inc. (HITI) is a Pharmaceutical Retailers stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

HITI

$2.70

+$0.05 (+1.89%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HITI with… →

HITI Key Statistics

As of Oct 21, 2026
Trading
Open
$2.63
Previous Close
$2.65
Day's Range
2.61–2.70
52-Week Range
2.02–3.50
Volume
245.72K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.95
Valuation
Market Cap
$240.69M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
20.85
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.33
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.31
Financials (FY)
Revenue (FY)
$593.99M+13.72%
Net Income (FY)
−$50.75M
Profit marginThe share of revenue left as profit after all costs and taxes.
−4.63%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
89.14M
1-Year Return
−18.67%
Dividend and dates
Avg Volume
597.73K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, HITI closed at $2.70, −18.67% over 1 year.

High Tide Inc. (HITI) has a market capitalization of $240.69M.

In fiscal 2025, HITI reported revenue of $593.99M.

HITI Stock Return by Calendar Year

High Tide Inc. (HITI) return since Jan 2021: what $10,000 became

1 year
$10,000 $8,133
−18.67%
5 years
$10,000 $4,712
−52.88%
Since Jan 2021
$10,000 $8,571
−14.29%

If you had invested $10,000 in High Tide Inc. (HITI) at the close on January 8, 2021, the earliest close on record here, it would have been worth $8,571 at the close on October 21, 2026: −14.29% in total, −2.63% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+1.89%
2025−14.24%
2024+89.57%
2023+5.84%
2022−63.76%
2021+34.92%

As of October 21, 2026.

HITI Revenue and Earnings by Fiscal Year

FY ends October
Fiscal yearRevenueNet incomeNet margin
2025$593.99M−$50.75M−8.5%
2024$522.31M−$4.34M−0.8%
2023$487.67M−$39.31M−8.1%
2022$356.85M−$71.76M−20.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$593.99M$153.53M$15.44M−$50.75M−8.5%
2024$522.31M$142.50M$15.32M−$4.34M−0.8%
2023$487.67M$131.31M−$2.66M−$39.31M−8.1%
2022$356.85M$100.95M−$20.11M−$71.76M−20.1%

Annual figures as reported, in the company's reporting currency. As of October 31, 2025.

HITI Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricHITIPharmaceutical Retailers medianvs median
P/S ratio0.330.2437% above
Profit margin−4.63%−17.34%12.7 pts above

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

High Tide Inc. (HITI) is capitalised at $240.69M on the latest close. The company sits in the Healthcare sector, in the Pharmaceutical Retailers industry. The company reports 1,832 employees.

Over the past 52 weeks the price has ranged from $2.02 to $3.50. HITI last closed at $2.70 on October 21, 2026. That is +$0.05 (+1.89%) against the previous close. The latest close sits 33.66% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $593.99M. Against the prior fiscal year total of $522.31M, that is a change of +13.72%. The same year closed with a net loss of $50.75M. Profit margin runs at −4.63%. That is 12.7 percentage points above the Pharmaceutical Retailers median of −17.34%. Earnings per share on a trailing basis come to −0.31.

Across the 4 fiscal years on file, revenue moves from $356.85M in 2022 to $593.99M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 20.85. The price-to-sales ratio is 0.33. On price-to-sales that is 37.24% above the Pharmaceutical Retailers median of 0.24. The medians here are taken across 6 Pharmaceutical Retailers companies that report the metric.

The trailing one-year total return is −18.67%. Across 5 years the annualized return works out at −13.97%. The reported beta is 0.95. Annualized volatility over the trailing 5 years is 62.3%.

Growth & Income

No dividend is on file for HITI.

Across the complete calendar years on file, 2024 returned +89.57% and 2022 returned −63.76%. Of the 5 complete calendar years on file, 3 finished higher. 2026 is still running; the total return is +1.89% year to date.

Peer Comparison

High Tide Inc. (HITI) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
High Tide Inc. HITI $240.69M —
TelyRx Holdings Inc. TELY.TO CA$66.48M —
Pomdoctor Limited POM $27.90M —
PetMed Express, Inc. PETS $25.80M —

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Pharmaceutical Retailers Stocks

View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products. The company also engages in data analytics; advertising; product sourcing and imports; event-based cannabis retail; medical cannabis distribution; accessories retail; and other related services. It provides its products under the Daily High Club, DankStop, FAB CBD, GC, Nuleaf Naturals, Smoke Cartel, Blessed CBD, Fastendr, Famous Brandz, Queen of Bud, Canna Cabana, Grasscity, Daily High Club, and Valiant Distribution brands. The company sells its products through a network of retail stores, e-commerce platforms, and the wholesale distribution arm. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. The company was founded in 2009 and is headquartered in Calgary, Canada.

Visit website →